These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2475955)

  • 21. Evaluation of human chorionic gonadotropin and alpha fetoprotein in benign and malignant testicular disorders.
    Moore MR; Garrett PR; Walton KN; Waldmann TA; McIntire RK; Vogel CL
    Surg Gynecol Obstet; 1978 Aug; 147(2):167-74. PubMed ID: 80036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of radioimmunoassay of human chorionic gonadotropin and alpha fetoprotein in nonseminomatous germ cell tumors of the testis.
    Kausitz J; Hupka S; Cerný V; Bohunický L; Korec S
    Neoplasma; 1980; 27(3):321-7. PubMed ID: 6161314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of tumour marker regression models in stage 1 marker-positive testicular cancer.
    May M; Helke C; Nitzke T; Seehafer M; Vogler H; Hoschke B
    Urol Int; 2004; 73(4):329-36. PubMed ID: 15604578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD; Patel MI; Sheinfeld J
    J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis of primary testicular seminoma: a report on 57 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Atypical symptoms in patients with germinal testicular tumors].
    Dieckmann KP; Krain J; Gottschalk W; Büttner P
    Urologe A; 1994 Jul; 33(4):325-30. PubMed ID: 7524231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only.
    Nicolai N; Miceli R; Artusi R; Piva L; Pizzocaro G; Salvioni R
    J Urol; 2004 Jan; 171(1):172-6. PubMed ID: 14665870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alpha-fetoprotein and chorionic gonadotropin in seminoma of the testis].
    Sakalo VS; Romanenko AM; Persidskiĭ IuV; Iugrinova LG
    Urol Nefrol (Mosk); 1988; (2):46-50. PubMed ID: 2455374
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor markers in testicular cancer.
    Catalona WJ
    Urol Clin North Am; 1979 Oct; 6(3):613-28. PubMed ID: 92089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.
    Murugaesu N; Schmid P; Dancey G; Agarwal R; Holden L; McNeish I; Savage PM; Newlands ES; Rustin GJ; Seckl MJ
    J Clin Oncol; 2006 Oct; 24(30):4862-6. PubMed ID: 17050871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of clinical stage I nonseminomatous germ cell testicular cancer.
    Choueiri TK; Stephenson AJ; Gilligan T; Klein EA
    Urol Clin North Am; 2007 May; 34(2):137-48; abstract viii. PubMed ID: 17484919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?
    Spiess PE; Brown GA; Pisters LL; Liu P; Tu SM; Evans JG; Kamat AM; Black P; Tannir NM
    Cancer; 2006 Oct; 107(7):1503-10. PubMed ID: 16944534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation therapy: a primary treatment modality for seminoma.
    Stutzman RE; McLeod DG
    Urol Clin North Am; 1980 Oct; 7(3):757-64. PubMed ID: 7456184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer.
    Spiess PE; Brown GA; Liu P; Tannir NM; Tu SM; Evans JG; Czerniak B; Kamat AM; Pisters LL
    Cancer; 2006 Oct; 107(7):1483-90. PubMed ID: 16944541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous measurement of tumor cytosol and peripheral serum levels of human chorionic gonadotropin and alphafetoprotein in testicular cancer.
    Javadpour N; Woltering E; Soares T
    Invest Urol; 1980 Jul; 18(1):11-2. PubMed ID: 6157650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of tumour markers and lymphography in determining clinical stage of non-seminomatous testis tumours.
    Zvara V; Hornák M; Breza J; Krídl J
    Czech Med; 1986; 9(1):9-14. PubMed ID: 2423305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of tumor markers in nonseminomatous germ cell tumor of the testis.
    Kulkarni JN; Kamat MR
    Eur Urol; 1993; 24(2):166-71. PubMed ID: 7690705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multivariate analysis of prognostic factors in advanced stage of non seminomatous germ cell tumors of the testis (NSGCTT).
    Droz JP; Kramar A; Caillaud JM; Bellet D; Wibault P; Court BH
    Prog Clin Biol Res; 1985; 203():269-70. PubMed ID: 2421329
    [No Abstract]   [Full Text] [Related]  

  • 39. [Staging evaluation and surveillance in tumors of the testicle].
    Pabot du Chatelard P; Cordoliani Y; Merrer J
    Ann Urol (Paris); 1992; 26(2):90-102. PubMed ID: 1377462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human chorionic gonadotropin and alphafetoprotein in the staging of nonseminomatous testicular cancer.
    Bosl GJ; Lange PH; Fraley EE; Goldman A; Nochomovitz LE; Rosai J; Waldmann TA; Johnson K; Kennedy BJ
    Cancer; 1981 Jan; 47(2):328-32. PubMed ID: 6161691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.